Will Parrish
Vice President, Strategy, Corporate Development, and Investor Relations
Replay available
Accendra Health, Inc. (NYSE: ACH) Q2 2026 earnings conference call, held 2026-08-10. Replay captured from the company's public earnings webcast.

Vice President, Strategy, Corporate Development, and Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Chief Operating Officer
Analyst, UBS
Analyst, Lear Inc. Partners
Analyst, J.P. Morgan
Analyst, Citi
Analyst, Bank of America
Good morning, and thank you for standing by. Welcome to the Accendra Health Second Quarter twenty twenty six Earnings Conference Call. Please be advised that today's conference call is being recorded. After the speakers' remarks, there will be a question and answer Thank you. I would now like to hand the conference call over to your first speaker today, Will Parrish, Vice President, Strategy, Corporate Development and Investor Relations. Thank you, operator, and good morning, everyone. I'd like to welcome you to Accendra Health's second quarter earnings call. Our comments on the call will be focused on the financial results of the second quarter of twenty twenty six, all of which are included in today's press release. The press release, along with the second quarter twenty twenty six supplemental slides, which we will refer to throughout the call, are posted in the Investor Relations section of our website. Please note that during this call, we will make forward looking statements that reflect current views of Accendra Health about our business, financial performance and future events. The matters addressed in these statements are subject to risks and uncertainties, which could cause actual results to differ materially from those projected or implied here today. Our expectations, beliefs and projections are expressed in good faith, and we believe there is reasonable basis for them. However, there can be no assurance that our expectations, beliefs and projections will result or be achieved. Please refer to our SEC filings for a full description of these risks and uncertainties, including the Risk Factors section of our annual report on Form 10 ks and quarterly reports on Form 10 Q. Any forward looking statements that we make on this call, in our earnings press release...